To map the organisation of nutrient signalling pathways
Lead Research Organisation:
Babraham Institute
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
We propose to begin to characterize the responses of freshly-prepared, collagenase-liberated isolated mouse hepatocytes to a range of specific nutrient challenges, that cannot be applied in vivo, in terms of their effect on the class I & III PI3K pathways to mTor, mTor activity, the intiation of autophagy and ROS production. So that in the second half of the project we can look at aged and diet-restricted animals. We aim to publish our first major study indicating that amino acids controlling mTor activity are taken-up by macro-pinocytosis and to have advanced our work addressing the nature of the Ca2+ signals controlling mTor at lysosomes near to a point of submission. We will have tested several amino acid analogues for their effect on mTORC1 activation and then image their distribution within cells. A project following-up the confirmed hits from our genome-wide screens for suppressors and activators of vps34 complexes in autophagy. This work will focus on specific hypotheses arising from that work using a combination of molecular, cell biology and systems approaches to assemble subsets of hits into meaningful regulatory networks. Within that project we aim to have isolated the subset of hits that appear to affect mTORC1 localization and activity and begun to generate a signalling diagram leading from starvation to autophagy. We will have begun to analyse the products of DAz-2 derivatised cell lysates to reveal the complexity of the samples we will be attempting to analyse. Following on from our new data we will define the activation status of ERK1/2, p38, MNK1/2 and eIF4E during nutrient starvation and during acute and chronic mTOR inhibition in primary human fibroblasts and assess their activation in young and aged fibroblasts. This will be a pre-requisite to gene expression studies and analysis of young and aged samples.
Planned Impact
unavailable
Organisations
- Babraham Institute (Lead Research Organisation)
- Medical Research Council (MRC) (Collaboration)
- University of Tromso (Collaboration)
- University College London (Collaboration)
- Columbia University Medical Center (Collaboration)
- Casma Therapeutics (Collaboration)
- Osaka University (Collaboration)
- UNIVERSITY OF CAMBRIDGE (Collaboration)
- French National Institute of Agricultural Research (Collaboration)
- AstraZeneca (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- Albert Einstein College of Medicine (Collaboration)
- Leibniz Association (Collaboration)
- UNIVERSITY OF DUNDEE (Collaboration)
- UNIVERSITY OF SOUTHAMPTON (Collaboration)
Publications

Alissafi T
(2020)
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.
in Cell metabolism

Alliouachene S
(2015)
Inactivation of the Class II PI3K-C2ß Potentiates Insulin Signaling and Sensitivity.
in Cell reports


Anderson KE
(2016)
Investigating the effect of arachidonate supplementation on the phosphoinositide content of MCF10a breast epithelial cells.
in Advances in biological regulation


Barneda D
(2022)
Acyl chain selection couples the consumption and synthesis of phosphoinositides.
in The EMBO journal

Bentires-Alj M
(2015)
Stimulating translational research: several European life science institutions put their heads together.
in Trends in molecular medicine

Bulley SJ
(2016)
In B cells, phosphatidylinositol 5-phosphate 4-kinase-a synthesizes PI(4,5)P2 to impact mTORC2 and Akt signaling.
in Proceedings of the National Academy of Sciences of the United States of America

Bussi C
(2018)
Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells.
in Journal of cell science

Cader MZ
(2016)
C13orf31 (FAMIN) is a central regulator of immunometabolic function.
in Nature immunology
Description | mTOR is a master regulator of nutrient status. In organisms as diverse as worms, flies, mice and men it coordinates how cells respond to changes in nutrient availability. In addition, drugs that inhibit mTOR can mimic nutrient starvation and increase lifespan in several organisms and can make longer lived organisms healthier (increasing their healthspan). We discovered how mTOR, an important kinase that regulates autophagy, traffics on and off lysosomes in response to amino acids. We also discovered how the earliest autophagy intermediate looks like by combining live imaging and super resolution microscopy. In addition we have discovered one mechanism by which cells are able to adapt to long-term inhibition of mTOR. This may be relevant to models of lifespan/healthspan extension and also to possible therapeutic uses of mTOR inhibitors. |
Exploitation Route | The dynamics of the processes that we described can be analyzed in neuronal cells undergoing neurodegeneration, or in cells as they age, in order to assay the benefits of potential drugs. Indeed, understanding how cells adapt to long-term mTOR inhibition will be important to pharmaceutical companies seeking to develop mTOR inhibitors of treatment of disease |
Sectors | Education Healthcare Pharmaceuticals and Medical Biotechnology |
Description | Reagents and assays developed have been used to set up a screening platform for identification of novel autophagy modulators. This has been funded by the Institute and is using a chemical library provided by MRC-T. We have also generated immortalised human cell lines that have adapted to chronic mTOR inhibition (which mimics nutrient starvation) and investigated the underlying mechanisms of adaptation. These cell lines have been made available to other academics and industrial collaborators. For example, AstraZeneca are developing mTOR inhibitors for the treatment of malignancy and are interested in how cells adapt and acquires resistance to such drugs and this will help them to maximise drug efficacy and identify patient populations most likely to respond. |
First Year Of Impact | 2014 |
Sector | Education,Healthcare,Pharmaceuticals and Medical Biotechnology |
Impact Types | Economic |
Description | Babraham Institute Representative on Translational Research at EU Life, a consortium of EU Life Sciences Institutes |
Geographic Reach | Europe |
Policy Influence Type | Membership of a guideline committee |
URL | http://eu-life.eu/ |
Description | BBSRC Response mode project grant |
Amount | £322,649 (GBP) |
Funding ID | BB/L008793/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2013 |
End | 08/2017 |
Description | BBSRC Response mode project grant |
Amount | £327,000 (GBP) |
Funding ID | BB/P007015/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 05/2017 |
End | 05/2020 |
Title | IKKalpha and IKKbeta KO cell lines |
Description | We have generated HCT116 cell lines lacking one or other or both (DKO) of the critical NFkB activating protein kinases IKKalpha or IKKbeta using CRISPR/Cas9 gene targeting. In addition we have generated SW620 cell lines lacking either IKKalpha or IKKbeta using CRISPR/Cas9 gene targeting |
Type Of Material | Cell line |
Year Produced | 2022 |
Provided To Others? | Yes |
Impact | Too early for impacts; cells still being charatcerised. These will be made available to the community in the future |
Title | Inducible DYRK1B cells |
Description | HEK293 cells lines engineered to exhibit Tet-inducible expression of the DYRK1B protein kinase |
Type Of Material | Cell line |
Provided To Others? | No |
Impact | New knowledge of the biological function of the DYRK1B protein kinase, including new substrates. New research papers New collaborations |
Title | Inducible DYRK2 cell line |
Description | HEK293 cells lines engineered to exhibit Tet-inducible expression of the DYRK2 protein kinase |
Type Of Material | Cell line |
Provided To Others? | No |
Impact | New knowledge of DYRK2 Identification of new substrates of DYRK2 |
Title | Pathway analysis |
Description | Development of pathway analysis allowing for identification of enzyme activities modulated by cell stimulation, infection or metabolic change utilising novel bioinformatics methods. |
Type Of Material | Model of mechanisms or symptoms - mammalian in vivo |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | Identification of potential therapeutic targets to treat infection. |
Title | mTORi resistant cell lines |
Description | We have generated human cell lines (cancer cells and primary human fibroblasts) with adaptive resistance to the mTOR inhibitors rapamycin and AZD8055 |
Type Of Material | Cell line |
Year Produced | 2012 |
Provided To Others? | Yes |
Impact | Two papers have been published and this has provided insight in to likely mechanisms by which cancer cells may adapt and acquire resistance to mTOR inhibitors |
Title | DUB RNAi screen |
Description | In collaboration with MISSION Therapeutics we have undertaken an RNAi screen with human deubiquitylating enzymes (DUBs) to identify those DUBs that confer protection against ERK pathway, mTOR inhibition or PERK inhibition Datat is currently being analysed before candidates are selected for further characterisation |
Type Of Material | Database/Collection of data |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | Too early for impacts This data will be made available to the community in the future |
Description | AstraZeneca mTOR |
Organisation | AstraZeneca |
Country | United Kingdom |
Sector | Private |
PI Contribution | Inhibitors of mTOR promote healthy lifespan extension in model organisms by promoting autophagy and are also undergoing evaluation as a treatment for cancer. However, complete mTOR inhibition is not compatible with life. We are interested in how the mTOR pathway is remodelled during chronic exposure to mTOR inhibitors. We have generated cells that are resistant to mTOR inhibitors and examined the mTOR pathway to identify changes that underpin resistance. |
Collaborator Contribution | Our partners at AstraZeneca part funded a BBSRC PhD student to do this work, provided large quantities of mTOR inhibtor as an 'in kind' contribution and performed next gen sequencing and other analyses of resistant cells to probe for mechanisms of resistance |
Impact | The PhD student successfully completed their PhD, two papers have been published and additional work is ongoing. |
Start Year | 2011 |
Description | Collaboration on new targets of neurodegeneration involving autophagy |
Organisation | University of Cambridge |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Identify targets using cell biological assays |
Collaborator Contribution | Provide relevant assays |
Impact | not yet |
Start Year | 2021 |
Description | Collaboration with Casma Thereapeutics |
Organisation | Casma Therapeutics |
Country | United States |
Sector | Private |
PI Contribution | We have provided intelectual knowledge and insights into the non-canonical autophagy pathway. We have shared reagents and performed experiments. |
Collaborator Contribution | Casma have contributed reagemts, experiments and data. |
Impact | Thus far this collaboration has resulted in a presention of data as an invited speaker at a Gordon Research Conference. Based on this collaboration we have published a manuscript in Science Advances, 2021. |
Start Year | 2019 |
Description | Di Christofano_PIP3_mouse_Thyroid |
Organisation | Albert Einstein College of Medicine |
Country | United States |
Sector | Academic/University |
PI Contribution | Technical expertise: we measured PIP3 by mass spectrometry in their mouse thyroid biopsies |
Collaborator Contribution | They provided the main intellectual input and the mouse thyroid samples. |
Impact | Orlacchio A, Ranieri M, Brave M, Arciuch VA, Forde T, De Martino D..... Di Cristofano A, (2017). SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.. Cancer research, 77 (24), pp. 6914-6926 |
Start Year | 2016 |
Description | Divecha |
Organisation | University of Southampton |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Measurement of phosphoinositides. GM mouse projects progressed. |
Collaborator Contribution | Preparation of cell extracts |
Impact | Multi-disciplinary, we do lipidomics and mouse work. They do cell line experiments and cancer related experiments |
Start Year | 2012 |
Description | Divecha - phosphoinositides |
Organisation | University of Southampton |
Department | Primary Care and Population Sciences |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | expertise, reagents, measurements of phosphoinositides by mass spectrometry |
Collaborator Contribution | Intellectual framework for study, biological samples |
Impact | Stijf-Bultsma et al (2015) Mol Cell. 58(3):453-67. doi: 10.1016/j.molcel.2015.03.009. Jones et al (2015) FEBS 281(16):3591-608. doi: 10.1111/febs.12879. |
Description | Doreen Cantrell |
Organisation | University of Dundee |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Measurements of phosphoinositides |
Collaborator Contribution | Samples of lymphocytes |
Impact | Publications that are fully reported |
Start Year | 2014 |
Description | Herve Gillou |
Organisation | French National Institute of Agricultural Research |
Department | INRA laboratory Toxalim |
Country | France |
Sector | Public |
PI Contribution | Measurements of Phosphosphoinositides |
Collaborator Contribution | Preparation of cell samples, dietary manipulation of mice, eg high fat diet |
Impact | Multi-discipllinary, We perform lipidomics , Toulouse group deal with mouse models and diet manipulation |
Start Year | 2013 |
Description | Irvine_PI5P4K alpha |
Organisation | University of Cambridge |
Department | Department of Pathology |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We measured phosphoinositides by mass spectrometry |
Collaborator Contribution | They designed the study and provided biological material |
Impact | Bulley SJ, Droubi A, Clarke JH, Anderson KE, Stephens LR, Hawkins PT, Irvine RF. Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10571-6. doi: 10.1073/pnas.1522478113. |
Start Year | 2014 |
Description | Mitophagy in human patients |
Organisation | University of Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Examining human fibroblasts from patients with mitochondrial dysfunction to identify those with mitophagy alterations |
Collaborator Contribution | Provision of patient fibroblasts and patient histories |
Impact | still in progress |
Start Year | 2018 |
Description | Novel targets of autophagy using structural information and AI |
Organisation | University of Cambridge |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | A collaboration with two academic labs in the UK and Australia, together with a biotechnology company in Singapore in order to identify and characterize small molecules that activate selective autophagy against specific targets. My contribution thus far is in identifying ways to select targets, and to select the autophagy machinery that needs to be activated. |
Collaborator Contribution | The academic partners provide additional information on target selection and validation. The commercial partners provide AI support and chemical synthesis capability. |
Impact | We are in early steps of discussions and target selection |
Start Year | 2021 |
Description | Parsons - PREX |
Organisation | Columbia University Medical Center |
Country | United States |
Sector | Academic/University |
PI Contribution | Analysis of phosphoinositides by mass spectrometry |
Collaborator Contribution | Intellectual frame work for study and biological material |
Impact | Hodakoski et al (2014) Proc Natl Acad Sci U S A. 111(1):155-60. doi: 10.1073/pnas.1213773111. Epub 2013 Dec 23. |
Start Year | 2012 |
Description | Roger Williams |
Organisation | Medical Research Council (MRC) |
Department | MRC Laboratory of Molecular Biology (LMB) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Exchange of reagents and cell lines |
Collaborator Contribution | Exchange of reagents and cell lines |
Impact | Publications and grants |
Start Year | 2012 |
Description | Tamotsu |
Organisation | Osaka University |
Country | Japan |
Sector | Academic/University |
PI Contribution | Papers together |
Collaborator Contribution | Papers together |
Impact | Published 2 papers together |
Start Year | 2009 |
Description | Van haesebroeck - PI3K |
Organisation | University College London |
Department | UCL Cancer Institute |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Intellectual input, reagents and mass spectrometric analysis of phosphoinositides |
Collaborator Contribution | Intellectual input, biological samples. Wide ranging collaboration covering several projects. |
Impact | Alliouachene et al (2015) Cell Rep. 13(9):1881-94. doi: 10.1016/j.celrep.2015.10.052 Gyori et al (2014) Arthritis Rheumatol. 66(8):2210-21. doi: 10.1002/art.38660. Kulkarni et al (2011) Sci Signal. 4(168):ra23. doi: 10.1126/scisignal.2001617. |
Start Year | 2009 |
Description | Volker Haucke |
Organisation | Leibniz Association |
Department | Leibniz-Institute for Molecular Pharmacology |
Country | Germany |
Sector | Academic/University |
PI Contribution | Measurements of phopshoinositides and advice about assays for inostiol phosphates |
Collaborator Contribution | They have established assays of intracellualr trafficking using high content imaging technology and to measure mTOR1 distribution and roles. |
Impact | Multi-disciplinary, high content imaging, mass spectrometry, biochemisty |
Start Year | 2015 |
Description | p62 phosphorylation |
Organisation | University of Tromso |
Department | Department of Medical Biology |
Country | Norway |
Sector | Academic/University |
PI Contribution | Sharing of data; discussion of new experimental directions; experiments We have identified p62/SQSTM1 as a novel substrate of DYRK1B and DYRK2. We are investigating the role of this phosphorylation on p62 functions in proteostasis, stress responses and nutrient signalling |
Collaborator Contribution | Terje Johansen's lab will share reagents and expertise and perform specific experiments to define the interaction between DYRKs and p62 |
Impact | Too soon for any specific outputs as the collaboration has only just started. However, i have visited the University of Tromso and presented two Lectures as part of a PhD training course |
Start Year | 2017 |
Title | Identification of Deubiquitylating enzymes that arbitrate cell death in response ot ERK pathway or mTOR inhibition |
Description | In collaboration with MISSION Therapeutics the PhD student has screened and identified DUBs that determine whether ERK pathway or mTOR inhibition leads ot cell death or not. These might be potential drug targets |
IP Reference | |
Protection | Protection not required |
Year Protection Granted | 2017 |
Licensed | Commercial In Confidence |
Impact | Too early for direct impacts. Further validation and characterisation required |
Title | Identification of genes/enzymes driving resistance to mTOR inhibitors |
Description | Identification of genes/enzymes driving acquired resistance to mTOR inhibitors - these are possibly druggable targets for overcoming acquired resistance |
IP Reference | |
Protection | Protection not required |
Year Protection Granted | |
Licensed | Yes |
Impact | Too early to say but these genes/enzymes are possibly druggable targets for overcoming acquired resistance |
Title | SBpipe |
Description | This package contains a collection of pipelines for dynamic modelling of biological systems. It aims to automate common processes and speed up productivity for tasks such as model simulation, single and double parameter scan, and parameter estimation. |
Type Of Technology | Software |
Year Produced | 2017 |
Open Source License? | Yes |
Impact | Streamlined model identifiability and parameter estimation in systems biology modelling. |
URL | https://pdp10.github.io/sbpipe/ |
Description | Ageing research working group |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | working group aiming to define the physiological society's policy on research into ageing and the societal consequences. This was used to inform the Department of Health and the public. |
Year(s) Of Engagement Activity | 2018,2019 |
Description | Cambridge Enterprise & Technology Club |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Talk on autophagy and degenerative diseases |
Year(s) Of Engagement Activity | 2016 |
URL | http://www.cetc.info/degenerative-diseases/ |
Description | Cambridge Hellenic Learned Society |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | President of Society of Greek and Cypriot academics in Cambridge, charged with organizing events with well-known speakers in the fields of Science of Humanities and addressed to a lay/educated audience. So far we have organized 7 such events with average attendance of 90 people. |
Year(s) Of Engagement Activity | 2014,2015,2016 |
URL | https://camlearnhelsoc.wordpress.com/ |
Description | Computational Modeling in Biology Network |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | I created COMBINE to coordinate the development of standards in computational systems biology. The initiative includes several workshops a year (discussion of future standards, implementation of current standards, and end-user training), diffusion lists, social media dissemination. |
Year(s) Of Engagement Activity | 2011,2012,2013,2014,2015,2016,2017,2018 |
URL | http://co.mbine.org |
Description | Development strategy council |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Part of an international panel of experts convened by the Greek Economic Ministry to help develop Biotech industries in Greece |
Year(s) Of Engagement Activity | 2017 |
Description | In conversation with the Babraham Institute - part of Cambridge Science Festival |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | 1:1 dialogue with general public (open invitation but registration required for numbers). Evening reception in which we explain our science and answer questions Part of a programme of events for the annual Cambridge Science Festival |
Year(s) Of Engagement Activity | 2017 |
Description | Interview with PBS USA |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Interviewed about effect of Brexit upon UK science and innovation |
Year(s) Of Engagement Activity | 2017 |
Description | Invited lecturer to international meetings (average 2-3 per year) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | promoted discussions, collaborations scientific collaborations, joint grants and publications |
Year(s) Of Engagement Activity | Pre-2006,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019 |
Description | Invited lecturer to international meetings (average 2-3 per year) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Generated discussion, exchange of ideas and collaborations |
Year(s) Of Engagement Activity | Pre-2006,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019 |
Description | Invited talk at scientific meetings |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Invited talks at international meetings in Japan (June 2017), Finland (September 2017), Croatia (September 2017), Argentina (November 2017) |
Year(s) Of Engagement Activity | 2017 |
Description | Lipidomics workshops and lipid databasing, standards and nomenclature |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Establishing internationally agreed format for reporting lipid mass spectrometry data, agreeing structures for archiving of lipidomics data, international links, transfer of LIPID MAPS website and databasing capability from USA to Babraham and Cardiff |
Year(s) Of Engagement Activity | Pre-2006,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019 |
Description | Presentation at Campus Science Week |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Industry/Business |
Results and Impact | The focus of this event was to promote the research being undertaken by groups at the Babraham Institute and in Babraham Research Campus companies, to highlight campus scientific capabilities and support discovery of new collaboration opportunities. I participated by giving a short research talks highlighting the activities in my group. |
Year(s) Of Engagement Activity | 2020 |
URL | https://www.eventbrite.co.uk/e/babraham-science-week-registration-125319619355 |
Description | Public feedback exercise |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | The Signalling Department, in parallel with other BI departments, presented our research to a professionally selected sample of the UK public with the interntion of gaining public feedback on our institute and research. |
Year(s) Of Engagement Activity | 2015 |
Description | School visits |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | The students were enthused about the topic of my presentation and this led to dialogue and discussion about several issues including new cancer therapies, evolution of drug resistance in cancer, the use of animals in research. Anecdotally, the institute received requests for summer placement students following this visit. |
Year(s) Of Engagement Activity | 2014,2015,2016,2017,2018,2019 |
Description | Schools day |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | 125 pupils attended schools day, talks given to all and lab practicals ran for two small groups. |
Year(s) Of Engagement Activity | 2018,2019 |
Description | Science Open Day |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | Students visited the lab and undertook small lab-based proejcts supervised by students/post-docs and myself. I explained the research that we do and discussed ethical issues such as the use of animals in research. This precipitated excellent discussion and dialogue. We received excellent feedback from the schools involved and requests for further outreach activities |
Year(s) Of Engagement Activity | 2013,2014,2015,2016,2017,2018,2019,2020 |
Description | SysMod 2017 |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | I organised the 2nd meeting of the ISCB Community of Special Interest SysMod. Up to 270 people attended depending on the talk. |
Year(s) Of Engagement Activity | 2017 |
Description | Visits by Teachers |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | My lab has hosted 6th form Biology teachers who were visiting my Institution during Half Term to update their knowledge as part of their CPD |
Year(s) Of Engagement Activity | 2016,2017,2018,2019,2020 |
Description | WT/EBI course in silico systems biology |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | I organised this one-week course, and gave presentations entitled: "What is Systems Biology? Where does it come from?", "The many faces of modelling in biology", "Modelling in systems biology, a few challenges", "From art to engineering: two decades of standards and tools towards digital organisms", "Modelling chemical kinetics" plus a tutorial on stochastic simulations of biological systems. |
Year(s) Of Engagement Activity | 2017 |
Description | eLife Community Webinar - Refreshing approaches to researcher evaluation |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | I animated a webinar discussing various ways to bypass the traditional publication-based evaluation of researchers. |
Year(s) Of Engagement Activity | 2017 |